期刊文献+

鼻吸入布地奈德对支气管哮喘的影响

The Influence Of Rhinocort Inhalation To Allergic Rhinitis On Bronchial Asthma
下载PDF
导出
摘要 目的研究鼻局部吸入布地奈德治疗过敏性鼻炎对哮喘发作的影响。探讨患者用布地奈德治疗过敏性鼻炎对哮喘症状及肺功能变化的影响。方法采用临床试验方法研究门诊63例支气管哮喘合并过敏性鼻炎患者。随机分为布地奈德组(30例)和对照组(33例)。所有患者均规律经口吸入哮喘常规药物,布地奈德组规律加用鼻吸布地奈德。随访12周后再次进行研究,比较患者哮喘症状以及肺功能变化。结果布地奈德组在经过鼻吸布地奈德12周后与对照组ACT记分和肺功能比较有统计学意义(P<0.01)。2组在治疗前的差异无统计学意义(P>0.05)。结论过敏性鼻炎是哮喘发病的危险因素,鼻局部吸入布地奈德治疗伴有轻、中度哮喘的过敏性鼻炎患者,当鼻炎症状改善的同时,哮喘症状亦获得缓解,气道反应性降低。 Objective To study the influence of nasal glucocorticoid inhalation on allergic rhinitis complicated with asthma.To exploring the effect of rhinocort in allergic rhinitis on asthmatic symptom and variation of lung function.Methods 63 cases of outpatients suffered from allergic rhinitis comolicated with bronchial asthma were investigated in clinical method.They were divided into the rhinocort group(30 cases) and control group(33cases) randomly.All the people inhaled routine asthmatic medicine regularly.The rhinocort group add nasal rhinocort inhalation.Two groups were observed for 12 weeks.After 12 weeks,they were observed again from the symptom of asthma and the variation of lung function.Results There were statistical difference in the symptom of asthma and the variation of the lung function between the rhinocort group and the contronl group after 12 weeks(P0.01).However there were no statistical difference between the two groups at the begin of the treatment(P0.05).Conclusion Allergic rhnitis is a risk factor in the attack of asthma.Nasal inhalation of rhinocortcan improve the asthmatic symptoms and pulmonary function for patients with allergic rhinitis complicated by airway resistance or asthma.
作者 鲁春慧 卫杰
出处 《中外医疗》 2011年第8期20-21,共2页 China & Foreign Medical Treatment
关键词 鼻炎 变应性 哮喘 布地奈德 Rhinitis Allergy Asthma Rhinocort
  • 相关文献

参考文献11

  • 1Salib RJ,Drake Lee A,Howarth PH.Allergic rhinitis:past,present and the future[J].Clinotolaryngol,2003,28(4):291 - 295.
  • 2Bousquet J,van Cauwenberge P,Khahaev N,et al.Allergic rhinitis and its impact on asthma[J].Allergy Clin Immunol,2001,108(5): 147- 334.
  • 3中华医学会耳鼻咽喉科学分会.过敏性鼻炎诊断标准及疗效评定标准(1997年,中华耳鼻咽喉科杂志编辑委员会,海口).中华耳鼻咽喉科杂志,1998,.
  • 4中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3563
  • 5Corren J.The impact of allergic rhinitis on bronchial asthma[J]. Allergy Clin Immunol,1998,101(9):352- 356.
  • 6Campball GD,File TM,Lillington,et al.Trends in respiratory medicine:asthma and allergy[J].Respir Dis,1999,20(10):676.
  • 7Mygind N,Nielsen LP,Hoffmann HJ,et al.Mode of action of intra- nasal corticosleroids[J].Allergy Clin Immunol,2001,108(1):S16- 25.
  • 8Nielsen LP,Mygind N,Dahl R.Intranasal corticosteroids for aller- gic rhinitis superior relief [J].Drugs,2001,61(ll):1563-1579.
  • 9Davies RJ,Nelson HS.Once daily mometasonefuro at nasal spray: efficacy and safety of an new intranasal glucocorticoid for allergic rhinitis[J].Clin Ther,1997,19(1):27- 38.
  • 10Daley Yates PT, Baker RC.Systemic bioavail ability of fluticasone propionate administered as nasal drops and aqueous nasal spray for mulations [J].Brj Clin Pharmacol,2001,51 ( 1 ): 103 - 108.

共引文献3562

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部